Molecular Partners AG
MOLN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001745114
No open-market purchases or sales by Molecular Partners AG insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Molecular Partners AG as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 8
- −1 vs. Q4 2021
- Shares held
- 1.35M
- +193.2K (+16.6%) vs. Q4 2021
- Total value
- $27.6M
- +$5.21M (+23.3%) vs. Q4 2021
- New holders
- 2
- 1 more added
- Sold out
- 3
- 3 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MOLN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $13.8M |
| Q1 2026 | 4 | $14.2M |
| Q4 2025 | 6 | $15.6M |
| Q3 2025 | 6 | $13.3M |
| Q2 2025 | 6 | $13.7M |
| Q1 2025 | 6 | $14.2M |
| Q4 2024 | 5 | $17.0M |
| Q3 2024 | 5 | $4.20M |
| Q2 2024 | 8 | $6.18M |
| Q1 2024 | 8 | $3.83M |
| Q4 2023 | 8 | $3.91M |
| Q3 2023 | 7 | $3.91M |
| Q2 2023 | 7 | $5.73M |
| Q1 2023 | 6 | $5.60M |
| Q4 2022 | 8 | $5.99M |
| Q3 2022 | 8 | $6.17M |
| Q2 2022 | 8 | $5.93M |
| Q1 2022 | 8 | $27.6M |
| Q4 2021 | 9 | $22.4M |
| Q3 2021 | 9 | $27.7M |
| Q2 2021 | 15 | $35.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Molecular Partners AG; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 457,037 | $9.26M | 0.02% | +221,743+94.2% | Added |
| BVF Inc | 443,221 | $8.98M | 0.36% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 400,000 | $8.22M | 0.25% | 00.0% | Unchanged |
| Jane Street Group, LLC | 29,158 | $591.0K | 0.00% | −1,812−5.9% | Reduced |
| Millennium Management LLC | 23,942 | $485.0K | 0.00% | −8,383−25.9% | Reduced |
| UBS Group AG | 611 | $12.0K | 0.00% | −2,796−82.1% | Reduced |
| Morgan Stanley | 367 | $7.00K | 0.00% | +367 | New |
| Royal Bank of Canada | 300 | $6.00K | 0.00% | +300 | New |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −15,006−100.0% | Sold out |
| Westchester Capital Management, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |